Equity
Retained Earnings
AbbVie Retained Earnings decreased by 15.4% to -$17.87B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 87.6%, from -$9.53B to -$17.87B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows a downward trend with a 71.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 8, 2026
How to read this metric
A steady increase indicates consistent profitability and the ability to self-fund growth initiatives.
Detailed definition
Retained earnings represent the cumulative net income earned by the company since its inception, minus any dividends pai...
Peer comparison
Large-cap pharmaceutical companies typically show high retained earnings due to long-term profitability.
Metric ID:
retained_earningsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $740.00M | $1.60B | $3.13B | $5.10B | $3.52B | $4.95B | $4.78B | $2.39B | $1.79B | $933.00M | -$1.00B | -$2.38B | -$3.77B | -$4.96B | -$7.90B | -$9.53B | -$11.50B | -$14.23B | -$15.49B | -$17.87B |
| QoQ Change | — | +116.2% | +95.4% | +63.2% | -31.1% | +40.9% | -3.4% | -50.0% | -25.2% | -47.8% | -207.2% | -138.4% | -58.1% | -31.7% | -59.1% | -20.6% | -20.7% | -23.7% | -8.8% | -15.4% |
| YoY Change | — | — | — | — | +375.1% | +209.6% | +53.0% | -53.1% | -49.1% | -81.2% | -120.9% | -199.6% | -310.6% | -632.0% | -690.0% | -299.6% | -205.3% | -186.7% | -96.1% | -87.6% |
Range-$17.87B – $5.10B
CAGR+95.5%
Avg YoY Growth-148.4%
Median YoY Growth-108.5%
Current Streak14 quarters decline
Retained Earnings at Other Companies
Frequently Asked Questions
- What is AbbVie's retained earnings?
- AbbVie (ABBV) reported retained earnings of -$17.87B in Q1 2026.
- How has AbbVie's retained earnings changed year-over-year?
- AbbVie's retained earnings decreased by 87.6% year-over-year, from -$9.53B to -$17.87B.
- What is the long-term trend for AbbVie's retained earnings?
- Over 5 years (2020 to 2025), AbbVie's retained earnings has grown at a 71.1% compound annual growth rate (CAGR), from $1.06B to -$15.49B.
- What does retained earnings mean?
- The total profits a company has kept and reinvested in the business over time.